Top compounds associated with response to LRP1B


Feature Type Standardized
Nominal ANOVA
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.071 0.04
mRNA neratinib CTRPv2 pan-cancer AAC 0.074 0.04
mRNA MS-275 gCSI pan-cancer AAC -0.12 0.04
mRNA SB-225002 CTRPv2 pan-cancer AAC 0.064 0.04
mRNA QL-VIII-58 GDSC1000 pan-cancer AAC 0.093 0.04
mRNA QL-XII-47 GDSC1000 pan-cancer AAC 0.066 0.04
mRNA parbendazole CTRPv2 pan-cancer AAC 0.063 0.04
mRNA paclitaxel CCLE pan-cancer AAC 0.092 0.04
mRNA AZD7762 GDSC1000 pan-cancer AAC 0.065 0.04
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.073 0.04
Download CSV